58
The potential applications of this breakthrough extend to the treatment of hereditary diseases such as cystic fibrosis, muscular dystrophy, and certain types of cancer. The improved accuracy of the CRISPR-Cas9 Prime system opens doors for therapeutic interventions that were previously considered too risky due to the potential for unintended genetic alterations.
